Simulations Plus, Inc. · NASDAQ:SLP
Simulations Plus — Q1 FY2019 Earnings Presentation
19 slides from Simulations Plus's earnings presentation, Jan 10, 2019
Slide 1: Q1FY2019 Investor Conference Call
Q1FY2019 Investor Conference Call Shawn O’Connor, CEO John Kneisel, CFO January 9, 2019 (NASDAQ:SLP)
Slide 2: Safe Harbor Statement
2 With the exception of historical information, the matters discussed in this presentation are forward - looking statements that involve a number of risks and uncertainties . The actual results of the Company could differ significantly from those statements . Factors that could cause or contribute t
Slide 3: Highlights
Highlights • Revenue growth consistent with 10 - 15% annual outlook – 6.6% growth for the quarter tracks seasonality trends – Software growth strong at 10% slightly better than expected – Services revenue up 3% constrained by existing capacity and ramp up of new personnel • New business closures at
Slide 4: Steady and Consistent Revenue Growth
Steady and Consistent Revenue Growth 4 Nasdaq: SLP More than a decade of consistent revenue growth $12.5 $13.8 $14.9 $16.8 $5.8 $6.1 $9.2 $12.9 $18.3 $19.9 $24.1 $29.7 FY 2015 FY 2016 FY 2017 FY 2018 Annual Revenue $ in millions Software Consulting Key Highlights • Q1 FY2019 Financial Highlights – R
Slide 5: Simulations Plus Division (Lancaster)
Simulations Plus Division (Lancaster) 5 Nasdaq: SLP The genesis of the company… providing software, training and consulting services $12.3 $13.7 $14.5 $15.7 $0.7 $0.8 $1.1 $1.8 $13.0 $14.5 $15.6 $17.5 FY 2015 FY 2016 FY 2017 FY 2018 Annual Revenue $ in millions Software Consulting Simulations Plus r
Slide 6: Cognigen Division (Buffalo)
Cognigen Division (Buffalo) 6 Nasdaq: SLP A leading provider of population modeling and simulation services for the pharma and biotech industries $0.2 $0.2 $0.2 $0.2 $5.1 $5.4 $7.1 $7.7 $5.3 $5.6 $7.3 $7.9 FY 2015 FY 2016 FY 2017 FY 2018 Annual Revenue $ in millions Software Consulting Key Highlight
Slide 7: DILIsym Division (RTP)
$0.2 $0.9 $1.0 $3.4 $1.2 $4.3 FY 2017 FY 2018 Annual Revenue $ in millions Software Consulting DILIsym Division (RTP) 7 Nasdaq: SLP A leading provider of software products and services in QST and QSP Key Highlights • Q1 FY2019 Financial Highlights – Revenue unchanged yr / yr – Revenue breakdown: 75%
Slide 8: Financial Results
Financial Results Nasdaq: SLP
Slide 9: Income Statement: 1QFY19 Versus 1QFY18
9 Income Statement : 1QFY19 Versus 1QFY18 ( in millions) Lancaster Buffalo North Carolina FY19 FY18 Diff % chg Net sales $ 4.4 $ 2.1 $ 1.1 $ 7.5 $ 7.1 $ 0.5 6.6% Gross profit 3.5 1.1 0.7 5.3 5.3 0.0 0.0% Gross profit margin 81.1% 53.1% 63.5% 70.8% 75.4% - 4.6% - 6.1% SG&A $ 1.6 $ 0.8 $ 0.4 $ 2.7 $ 2
Slide 10: Consolidated Revenues: Fiscal Quarter
10 Consolidated Revenues: Fiscal Quarter ( in millions) $4.0 $4.6 $5.9 $3.7 $4.8 $5.2 $6.0 $4.0 $5.4 $5.7 $6.8 $6.3 $7.1 $7.4 $8.6 $6.7 $7.5 $0 $1 $2 $3 $4 $5 $6 $7 $8 $9 $10 Q1 Q2 Q3 Q4 2015 2016 2017 2018 2019
Slide 11: Consolidated Income from Operations: Fiscal Quarter
11 Consolidated Income from Operations: Fiscal Quarter (in millions) $0.7 $1.5 $2.9 $0.8 $1.7 $1.7 $2.8 $1.0 $1.9 $1.8 $3.1 $1.4 $2.6 $2.4 $3.4 $1.9 $2.1 $0.0 $0.5 $1.0 $1.5 $2.0 $2.5 $3.0 $3.5 $4.0 Q1 Q2 Q3 Q4 2015 2016 2017 2018 2019
Slide 12: Consolidated Net Income: Fiscal Quarter
$0.5 $1.0 $1.9 $0.5 $1.1 $1.2 $1.9 $0.8 $1.4 $1.2 $2.1 $1.2 $1.7 $3.5 $2.4 $1.3 $1.5 $0.0 $0.5 $1.0 $1.5 $2.0 $2.5 $3.0 $3.5 $4.0 Q1 Q2 Q3 Q4 2015 2016 2017 2018 2019 $2.0 12 Note: 2Q18 $1.5M tax benefit of deferred tax adjustment Consolidated Net Income: Fiscal Quarter (in millions)
Slide 13: Consolidated Diluted Earnings Per Share: Fiscal Quarter
13 Consolidated Diluted Earnings Per Share: Fiscal Quarter $0.03 $0.06 $0.11 $0.03 $0.06 $0.07 $0.11 $0.05 $0.08 $0.07 $0.12 $0.06 $0.10 $0.19 $0.13 $0.07 $0.09 $0.00 $0.02 $0.04 $0.06 $0.08 $0.10 $0.12 $0.14 $0.16 $0.18 $0.20 Q1 Q2 Q3 Q4 FY15 FY16 FY17 FY18 FY19 $0.11 Note: 2Q18 $0.08 tax benefit o
Slide 14: Consolidated EBITDA: Fiscal Quarter
14 Consolidated EBITDA: Fiscal Quarter (in millions) $1.2 $2.0 $3.3 $1.2 $2.2 $2.2 $3.3 $1.5 $2.5 $2.3 $3.6 $2.0 $3.2 $3.1 $4.1 $2.6 $2.8 $0 $1 $2 $3 $4 $5 Q1 Q2 Q3 Q4 2015 2016 2017 2018 2019
Slide 15: Revenue by Region – YTD 2019
Revenue by Region – YTD 2019 Nasdaq: SLP Europe 13% North America 65% Asia 21% South America <1% Japan = 60% India = 15% China = 21% Korea = 3% 15 A global and diversified base of revenue
Slide 16: Cash Position Remains Excellent
16 Cash Position Remains Excellent (in millions) Over $30 million cash paid out over last five FYs $0.8 $0.8 $0.8 $0.9 $0.9 $0.9 $0.9 $0.9 $0.9 $0.9 $0.9 $0.9 $1.0 $1.0 $1.0 $1.1 $1.1 $2.1 $0.8 $0.7 $0.8 $1.0 $5.0 $5.1 $1.0 $5.8 $6.1 $6.4 $8.6 $7.2 $7.1 $8.8 $8.0 $8.8 $7.4 $8.2 $6.2 $7.0 $7.5 $7.2 $
Slide 17: Selected Consolidated Balance Sheet Items
17 Selected Consolidated Balance Sheet Items (in millions, except where indicated) November 30, 2018 August 31, 2018 Cash and cash equivalents $ 9.4* $ 9.4* Cash per share ( in Dollars ) $ 0.54 $ 0.54 Total current assets 17.4 17.8 Total assets 41.9 43.3 Total current liabilities 5.0 4.8 Total liabi
Slide 18: Products & Services
Products & Services Software Portfolio • Modeling & simulation platform for drug R&D • Predictive software for >140 properties of chemical formulations • Analytical software for certain biological or disease states • Cloud - based web app for drug development lifecycle management Consulting Services
Slide 19: Thank you!
19 Thank you! http://www.simulations - plus.com https://www.linkedin.com/company/95827/ https://www.linkedin.com/company/46152/